Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
05/20/2015 05/21/2015 05/22/2015 05/25/2015 05/26/2015 Date
8.08 8 8.55 8.12 9.06 Last
400 100 3572 1111 4300 Volume
-1.34% -0.99% +6.88% -5.03% +11.58% Change
Financials ( CAD)
Sales 2015 2,50 M
EBIT 2015 -
Net income 2015 -44,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 5,00 M
EBIT 2016 -
Net income 2016 -11,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 126x
Capi. / Sales 2016 63,1x
Capitalization 316 M
More Financials
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets.It operates through research and development of therapeutic agents segment.The company's products include ELND005 for the treatment of alzheimer's... 
Sector
Pharmaceuticals
Calendar
09/28Earnings Release
More about the company
Latest news on TRANSITION THERAPEUTICS IN
06:02a TRANSITION THERAPEUTICS : to Present at the Jefferies 2015 Healthcare Conference
05/12 TRANSITION THERAPEUTICS : Announces Third Quarter Fiscal 2015 Financial Results
05/07 TRANSITION THERAPEUTICS : to Hold Conference Call on Third Quarter Fiscal 2015 F..
05/06 TRANSITION THERAPEUTICS : In-Licenses Phase 2 Drug Candidate from Lilly
03/26 TRANSITION THERAPEUTICS : Announces Results from Phase 1 AME & Renal Clearance C..
03/02 TRANSITION THERAPEUTICS : Announces Enrolment Completion of ELND005 Phase 2 Clin..
02/24 TRANSITION THERAPEUTICS INC : LifeSci Capital Initiates Coverage of Transition T..
02/19 TRANSITION THERAPEUTICS : to Present at the Cowen and Company 35th Annual Health..
More news
Sector news : Biopharmaceuticals
08:15pDJNew Push Ties Cost of Drugs to How Well They Work
07:35p JOHNSON & JOHNSON : New Enterprise Florida chief defends incentives
07:01p ABBVIE : Presents New Data for its Investigational Hepatitis C Treatment in Japa..
More sector news : Biopharmaceuticals
News from SeekingAlpha
11:15a Transition Therapeutics - Can Lightning Strike Twice For Baker Brothers?
05/13 Transition Therapeutics net loss improves in FQ3
05/12 Transition Therapeutics' (TTHI) CEO Tony Cruz on Q3 2015 Results - Earnings C..
05/12 Transition Therapeutics reports FQ3 results
05/06 Transition Therapeutics licenses androgen receptor modulator from Lilly


Comments 
Advertisement
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions